The next frontier in developing therapies for cancer and other diseases could come through studying organ development or tumor growth in living humans. Problem is, there’s no ethical way of doing that using current technology.
Zev Gartner, PhD, has focused on the next best thing: His lab is building fully functioning 3-D human tissue, cell by cell.
Pharmaceutical Chemistry department members have received the following grants and fellowships between July and September 2015:
9/30/2015: Steven Altschuler's Convergence Scholar Award entitled, "The genetic, epigenetic, and immunological underpinnings of cancer evolution through treatment" was funded by The V Foundation. This award will be funded over a three-year period.
Gary Rudnick, PhD, will present “Conformational change in mechanism and regulation of serotonin transporter” on Monday, September 28, 2015, from noon to 1:00 pm, at the Gladstone Institutes, Robert W. Mahley Auditorium. The seminar is hosted by William DeGrado.
Rudnick is a professor of pharmacology at the Yale School of Medicine and a visiting scholar in the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry.
UCSF School of Pharmacy faculty member Leslie Benet, PhD, has been named the 2015 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX).
Sheng Ding, PhD, is a stem cell scientist who uses novel small molecules to control and reprogram stem cell activities in various tissue types. Applying his groundbreaking techniques, he has previously succeeded in transforming skin cells into functional brain, heart, liver, and insulin-producing pancreas cells.
A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN) will support the development of next-generation, antibody-based cancer therapies. The RAN is a consortium comprising researchers from the UCSF School of Pharmacy (UCSF Antibiome Center), the University of Chicago, and the University of Toronto.
Our research focuses on the application of modern chemical synthesis to biological challenges. Primary branches include complex molecule synthesis, reaction development, and de novo molecular design. Each project is chosen based on its fundamental scientific merit and its potential for immediate application.
